Phibro Animal Health Corporation (PAHC) Earnings History
Annual and quarterly earnings data from 2000 to 2025
Loading earnings history...
PAHC EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
PAHC Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 30.9% | 8.5% | 3.7% |
| 2024 | 30.8% | 5.2% | 0.2% |
| 2023 | 30.5% | 7.3% | 3.3% |
| 2022 | 30.3% | 8.4% | 5.2% |
| 2021 | 32.6% | 9.0% | 6.5% |
Download Data
Export PAHC earnings history in CSV or JSON format
Free sign-in required to download data
Phibro Animal Health Corporation (PAHC) Earnings Overview
As of May 8, 2026, Phibro Animal Health Corporation (PAHC) reported trailing twelve-month net income of $92M, reflecting +1883.3% year-over-year growth. The company earned $2.25 per diluted share over the past four quarters, with a net profit margin of 3.7%.
Looking at the long-term picture, PAHC's 5-year EPS compound annual growth rate (CAGR) stands at +7.5%, showing solid earnings momentum. The company achieved its highest annual net income of $83M in fiscal 2016.
Phibro Animal Health Corporation maintains positive profitability with a gross margin of 30.9%, operating margin of 8.5%, and net margin of 3.7%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including ELAN (-$242M net income, -4.9% margin), ZTS ($2.64B net income, 28.2% margin), NEOG (-$603M net income, -122.1% margin), PAHC has outperformed on profitability metrics. Compare PAHC vs ELAN →
PAHC Earnings vs Peers
Earnings metrics vs comparable public companies
PAHC Historical Earnings Data (2000–2025)
22 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $48M | +1897.7% | $110M | $1.19 | 3.7% | 8.5% |
| 2024 | $2M | -92.6% | $53M | $0.06 | 0.2% | 5.2% |
| 2023 | $33M | -33.7% | $72M | $0.81 | 3.3% | 7.3% |
| 2022 | $49M | -9.6% | $79M | $1.21 | 5.2% | 8.4% |
| 2021 | $54M | +62.1% | $75M | $1.34 | 6.5% | 9.0% |
| 2020 | $34M | -38.7% | $69M | $0.83 | 4.2% | 8.6% |
| 2019 | $55M | -15.7% | $73M | $1.35 | 6.6% | 8.9% |
| 2018 | $65M | +0.5% | $99M | $1.61 | 7.9% | 12.1% |
| 2017 | $65M | -21.9% | $98M | $1.61 | 8.5% | 12.8% |
| 2016 | $83M | +37.2% | $86M | $2.07 | 11.0% | 11.4% |
See PAHC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PAHC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PAHC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPAHC — Frequently Asked Questions
Quick answers to the most common questions about buying PAHC stock.
Is PAHC growing earnings?
PAHC EPS is $2.25, with earnings growth accelerating to +1883.3%. This exceeds the 5-year CAGR of +7.5%. TTM net income reached $92M.
What are PAHC's profit margins?
Phibro Animal Health Corporation net margin is +3.7%, with operating margin at +8.5%. Below-average margins reflect competitive or cost pressures.
How consistent are PAHC's earnings?
PAHC earnings data spans 2000-2025. The accelerating earnings trend is +1883.3% YoY. Historical data enables comparison across business cycles.